Financial statements Melisa Pharm
Balance sheet of Melisa Pharm
Company age:
Age:
15 y. 23 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of MELISA PHARM
|
Year
|
2022
|
2023
|
|---|---|---|
| Total assets | 4 839 193,38 | 4 050 958,24 |
| A. Fixed assets | 1 185 656,04 | 985 828,55 |
| B. Current assets | 3 653 537,34 | 3 065 129,69 |
| C. Share capital contributions (basic funds) | - | - |
| D. Own shares (stocks) | - | - |
| Total liabilities | 4 839 193,38 | 4 050 958,24 |
| A. Equity | 2 074 038,68 | 1 940 622,26 |
| B. Liabilities and provisions for liabilities | 2 765 154,70 | 2 110 335,98 |
| I. Long-term liabilities | - | - |
| II. Short-term liabilities | 2 589 455,96 | 1 978 041,78 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.